Sponsor Pipeline

Hangzhou Qihan Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07444307 A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic… Systemic Lupus Erythematosus (SLE) Recruiting
Disease Areas
Lupus (SLE) (1)
Get alerts when Hangzhou Qihan Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free